Foto del docente

Milo Gatti

Ricercatore a tempo determinato tipo a) (junior)

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio, Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2021, 76, pp. 199 - 205 [articolo]

Gatti, Milo; Raschi, Emanuel; Moretti, Ugo; Ardizzoni, Andrea; Poluzzi, Elisabetta; Diemberger, Igor, Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, «VACCINES», 2021, 9, pp. 1 - 13 [articolo]

Gatti, Milo; Pea, Federico, Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections?, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 403 - 407 [articolo]

Gatti M.; Giannella M.; Scudeller L.; Viale P., Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria, «THE LANCET INFECTIOUS DISEASES», 2020, 20, pp. 24 - 24 [replica/breve intervento]

Giannella M.; Bartoletti M.; Gatti M.; Viale P., Advances in the therapy of bacterial bloodstream infections, «CLINICAL MICROBIOLOGY AND INFECTION», 2020, 26, pp. 158 - 167 [articolo]

Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi, Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2020, 2020 Apr 20, pp. 1 - 9 [articolo]Open Access

Gatti M.; Bianchin M.; Raschi E.; De Ponti F., Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2020, 75, pp. 60 - 70 [articolo]

Bielli A.; Piazza A.; Cento V.; Comandatore F.; Lepera V.; Gatti M.; Brioschi P.; Vismara C.; Bandi C.; Perno C.F., In vivo acquisition and risk of inter-species spread of blaKPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract, «JOURNAL OF MEDICAL MICROBIOLOGY», 2020, 69, pp. 82 - 86 [articolo]

Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F., Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, «TARGETED ONCOLOGY», 2020, 15, pp. 449 - 466 [articolo]

Gatti M.; Poluzzi E.; De Ponti F.; Raschi E., Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, «DRUG SAFETY», 2020, 43, pp. 1277 - 1285 [articolo]

Gatti M., Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shock, «JOURNAL OF CHEMOTHERAPY», 2020, 32, pp. 208 - 212 [articolo]

Cento V.; Alteri C.; Mancini V.; Gatti M.; Lepera V.; Mazza E.; Moioli M.C.; Merli M.; Colombo J.; Orcese C.A.; Bielli A.; Torri S.; Gasparini L.E.; Vismara C.; De Gasperi A.; Brioschi P.; Puoti M.; Cairoli R.; Lombardi G.; Perno C.F., Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study, «MYCOSES», 2020, 63, pp. 1299 - 1310 [articolo]

Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements, «CLINICAL NUTRITION», 2020, 39, pp. 3854 - 3855 [replica/breve intervento]

Pujade I.; Perino J.; Mathieu C.; Arnaud M.; Raschi E.; Gatti M.; Bezin J.; Salvo F., Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis, «PHARMACOLOGICAL RESEARCH», 2020, 160, pp. 1 - 9 [articolo]

Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I., The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, «CURRENT HEART FAILURE REPORTS», 2020, 17, pp. 365 - 383 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.